Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary Dyskinesia

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4029-4035

  Rogers, Geraint B ^a,b   Carroll, Mary P ^c,d   Zain, Nur Masirah M ^e   Bruce, Kenneth D ^e   Lock, Karen ^d   Walker, Woolf ^d,f   Jones, Graeme ^c   Daniels, Thomas W V ^c   Lucas, Jane S ^d,f  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; CHILD; CILIARY DYSKINESIA; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FOLLOW UP; HAEMOPHILUS; HUMAN; LOWER RESPIRATORY TRACT; LUNG FUNCTION; LUNG LAVAGE; MALE; MICROBIAL COMMUNITY; NONHUMAN; POLYMERASE CHAIN REACTION; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; RALSTONIA; RESPIRATORY TRACT EXAMINATION; RESPIRATORY TRACT INFECTION; RNA SEQUENCE; SEQUENCE HOMOLOGY; STREPTOCOCCUS;

ADOLESCENT; ADULT; AGED; BACTERIA; BACTERIAL LOAD; BIOTA; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; HUMANS; KARTAGENER SYNDROME; MALE; METAGENOMICS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84889873865     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02164-13     Document Type: Article

References (34)

1. Lucas JSA, Walker WT, Kuehni CE, Lazor R. 2011. Primary ciliary dyskinesia, p 201-217. In Cordier J-F (ed), Orphan lung diseases. European Respiratory Society Monograph, vol 54.
2. Leigh MW, Zariwala MA, Knowles MR. 2009. Primary ciliary dyskinesia: improving the diagnostic approach. Curr. Opin. Pediatr. 21:320-325.
3. Walker WT, Jackson CL, Lackie PM, Hogg C, Lucas JS. 2012. Nitric oxide in primary ciliary dyskinesia. Eur. Respir. J. 40:1024-1032.
4. Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, Bartoloni L, Eber E, Escribano A, Haarman E, Hesselmar B, Hogg C, Jorissen M, Lucas J, Nielsen KG, O'Callaghan C, Omran H, Pohunek P, Strippoli MP, Bush A. 2009. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur. Respir. J. 34:1264-1276.
5. Chouaia B, Crotti E, Brusetti L, Daffonchio D, Essoussi I, Nouioui I, Sbissi I, Ghodhbane-Gtari F, Gtari M, Vacherie B, Barbe V, Medigue C, Gury J, Pujic P, Normand P. 2012. Genome sequence of Blastococcus saxobsidens DD2, a stone-inhabiting bacterium. J. Bacteriol. 194:2752-2753.
6. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR. 2004. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am. J. Respir. Crit. Care Med. 169:459-467.
7. Blainey PC, Milla CE, Cornfield DN, Quake SR. 2012. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci. Transl. Med. 4:153ra130. doi:10.1126 /scitranslmed.3004458.
8. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 42:5176-5183.
9. Rogers GB, Cuthbertson L, Hoffman LR, Wing PA, Pope C, Hooftman DA, Lilley AK, Oliver A, Carroll MP, Bruce KD, van der Gast CJ. 2013. Reducing bias in bacterial community analysis of lower respiratory infections. ISME J. 7:697-706.
10. Stressmann AF, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, Carroll MP, Hoffman L, Daniels TW, Patel N, Forbes B, Bruce KD. 2012. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the cystic fibrosis lung are stable and resilient. Thorax 67:867-873.
11. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. 2012. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185:1073-1080.
12. Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. 2013. The lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am. J. Respir. Crit. Care Med. 187: 1118-1126.
13. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177:995-1001.
14. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. 2012. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 7:e45001. doi:10.1371/journal.pone.0045001.
15. van der Gast CJ, Cuthbertson L, Pope CE, Marsh RL, Rogers GB, Smith-Vaughan HC, Redding GJ, Bruce KD, Chang AB, Hoffman L. 2013. Three clinically distinct chronic pediatric airway infections share a common core microbiota. J. Cyst. Fibros. Abstr. WS1.2.
16. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA. 2013. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8:e62917. doi: 10.1371/journal.pone. 0062917.
17. Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ. 2013. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68:731-737.
18. O'Callaghan C, Chilvers M, Hogg C, Bush A, Lucas J. 2007. Diagnosing primary ciliary dyskinesia. Thorax 62:656-657.
19. Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. 2008. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonellainfected pigs. Foodborne Pathog. Dis. 5:459-472.
20. Dowd SE, Callaway TR, Wolcott RD, Sun Y, McKeehan T, Hagevoort RG, Edrington TS. 2008. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol. 8:125. doi:10.1186/1471-2180-8 -125.
21. Eren AM, Zozaya M, Taylor CM, Dowd SE, Martin DH, Ferris MJ. 2011. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One 6:e26732. doi:10.1371/journal.pone.0026732.
22. Swanson KS, Dowd SE, Suchodolski JS, Middelbos IS, Vester BM, Barry KA, Nelson KE, Torralba M, Henrissat B, Coutinho PM, Cann IK, White BA, Fahey GC, Jr. 2011. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J. 5:639-649.
23. Coenye T, Spilker T, Reik R, Vandamme P, LiPuma JJ. 2005. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J. Clin. Microbiol. 43:3463-3466.
24. Coenye T, Vandamme P, LiPuma JJ. 2002. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg. Infect. Dis. 8:692-696.
25. Feizabadi MM, Majnooni A, Nomanpour B, Fatolahzadeh B, Raji N, Delfani S, Habibi M, Asadi S, Parvin M. 2010. Direct detection of Pseudomonas aeruginosa from patients with healthcare associated pneumonia by real time PCR. Infect. Genet. Evol. 10:1247-1251.
26. Marthin JK, Petersen N, Skovgaard LT, Nielsen KG. 2010. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am. J. Respir. Crit. Care Med. 181:1262-1268.
27. Ryan MP, Pembroke JT, Adley CC. 2006. Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism. J. Hosp. Infect. 62:278-284.
28. Ahrens R, Moll GA. 1970. A new budding bacterium from the Baltic Sea. Arch. Mikrobiol. 70:243-265. (In German.)
29. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. 1996. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur. Resp. J. 9:1601-1604.
30. Cystic Fibrosis Foundation. 1997. Patient data registry annual data report 1996. Cystic Fibrosis Foundation, Bethesda, MD.
31. Pifferi M, Bush A, Pioggia G, Caramella D, Tartarisco G, Di Cicco M, Zangani M, Chinellato I, Maggi F, Tezza G, Macchia P, Boner A. 2012. Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia. Thorax 67:993-999.
32. Brook I. 2011. Microbiology of sinusitis. Proc. Am. Thorac. Soc. 8:90-100.
33. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. U. S. A. 109:5809-5814.
34. Daniels TW, Rogers GB, Stressmann FA, van der Gast CJ, Bruce KD, Jones GR, Connett GJ, Legg JP, Carroll MP. 2013. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J. Cyst. Fibros. 12:22-28.